Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

Authors

Jennifer B Green, Duke University
Amy K Mottl, University of North Carolina
George Bakris, University of Chicago
Hiddo J L Heerspink, University of Groningen
Johannes F E Mann, Friedrich Alexander University
Janet B McGill, Washington University School of Medicine in St. Louis
Masaomi Nangaku, University of Tokyo
Peter Rossing, University of Copenhagen
Charlie Scott, Bayer PLC
Alain Gay, Bayer AG
Rajiv Agarwal, Indiana University

Journal

Nephrology dialysis transplantation

Publication Date

3-31-2023

Volume

38

Issue

4

First Page

894

Last Page

903

Document Type

Open Access Publication

DOI

10.1093/ndt/gfac198

Rights and Permissions

Jennifer B Green, Amy K Mottl, George Bakris, Hiddo J L Heerspink, Johannes F E Mann, Janet B McGill, Masaomi Nangaku, Peter Rossing, Charlie Scott, Alain Gay, Rajiv Agarwal, Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE), Nephrology Dialysis Transplantation, Volume 38, Issue 4, April 2023, Pages 894–903, https://doi.org/10.1093/ndt/gfac198. https://academic.oup.com/ndt/article/38/4/894/6608366?login=true. © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.

Recommended Citation

Green, Jennifer B; Mottl, Amy K; Bakris, George; Heerspink, Hiddo J L; Mann, Johannes F E; McGill, Janet B; Nangaku, Masaomi; Rossing, Peter; Scott, Charlie; Gay, Alain; and Agarwal, Rajiv, "Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)." Nephrology dialysis transplantation. 38, 4. 894 - 903. (2023).
https://digitalcommons.wustl.edu/oa_4/1458

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.